XML 47 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Derivative Instruments (Tables)
 6 Months Ended
Jul. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Outstanding Foreign Exchange Forward Contracts
As of July 31, 2021, the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany inventory sales, the resulting settlement of the foreign-currency-denominated intercompany accounts receivable, or both:
(in thousands)
Notional Amount (1)
Euro$123,157 
British pound$82,236 
Canadian dollar$18,181 
Japanese yen$7,120 
(1)    Amount reported is the U.S. Dollar notional amount outstanding as of July 31, 2021.
Location and Amounts of Derivative Fair Values on the Condensed Consolidated Balance Sheets
The fair value of derivative instruments is valued using quoted market prices of the same or similar instruments, adjusted for counterparty risk. The location and amounts of derivative fair values of foreign currency exchange forward contracts on the Condensed Consolidated Balance Sheets as of July 31, 2021 and January 30, 2021 were as follows:
(in thousands)LocationJuly 31, 2021January 30, 2021LocationJuly 31, 2021January 30, 2021
Derivatives designated as cash flow hedging instruments
Other current assets$1,872 $79 Accrued expenses$794 $4,694 
Derivatives not designated as hedging instruments
Other current assets— — Accrued expenses— — 
Total
$1,872 $79 $794 $4,694 
Location and Amounts of Derivative Gains and Losses on the Condensed Consolidated Statements of Operations and Comprehensive Loss
Information pertaining to derivative gains or losses from foreign currency exchange forward contracts designated as cash flow hedging instruments for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020 follows:
Thirteen Weeks EndedTwenty-six Weeks Ended
(in thousands)July 31, 2021August 1, 2020July 31, 2021August 1, 2020
Gain recognized in AOCL (1)
$1,084 $— $2,228 $12,235 
(Loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization (2)
$(1,697)$2,407 $(3,152)$5,777 
(1)Amount represents the change in fair value of derivative contracts. As a result of COVID-19, there was a significant change in the expected timing of previously hedged intercompany sales transactions, resulting in a dedesignation of the related hedge instruments during the twenty-six weeks ended August 1, 2020. At the time of dedesignation of these hedges, they were in a net gain position of approximately $12.6 million. Due to the extenuating circumstances leading to dedesignation, gains associated with these hedges at the time of dedesignation were deferred in AOCL until being reclassified into cost of goods sold, exclusive of depreciation and amortization when the originally forecasted transactions occurred and the hedged items affected earnings. Subsequent to the dedesignation of these hedges, these hedge contracts were settled in Fiscal 2020.
(2)Amount represents (loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization.

Substantially all of the unrealized gain will be recognized in costs of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) over the next twelve months.

Additional information pertaining to derivative gains or losses from foreign currency exchange forward contracts not designated as hedging instruments for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020 follows:
Thirteen Weeks EndedTwenty-six Weeks Ended
(in thousands)July 31, 2021August 1, 2020July 31, 2021August 1, 2020
Gain (loss) recognized in other operating income, net$304 $— $(164)$742